About the Journal

Aim of the Journal:

Endocrinology & Metabolism International is dedicated to advancing knowledge and promoting innovation in the fields of endocrinology and metabolism. The journal aims to serve as a global platform for the publication of cutting-edge original research, reviews, clinical studies, and case reports that contribute to the understanding, diagnosis, treatment, and management of endocrine and metabolic disorders. By providing a robust and accessible platform for both emerging and established researchers, the journal strives to enhance clinical practices, improve patient outcomes, and address challenges related to endocrine and metabolic health.

Scope of the Journal:

Endocrinology & Metabolism International welcomes contributions from researchers, clinicians, and healthcare professionals working in all areas of endocrinology and metabolism. The journal covers a broad range of topics, including but not limited to:

  1. Endocrine Disorders:
    • Disorders of the thyroid, parathyroid, pituitary, adrenal glands, and hypothalamus
    • Diseases related to pancreatic endocrine function, including diabetes mellitus
    • Gonadal disorders, reproductive endocrinology, and disorders of sexual development
    • Growth and developmental disorders, including dwarfism, gigantism, and acromegaly
  2. Metabolic Disorders:
    • Obesity, metabolic syndrome, and lipid metabolism
    • Insulin resistance, glucose metabolism, and related conditions such as diabetes
    • Calcium and bone metabolism, including osteoporosis, osteomalacia and hyperparathyroidism
    • Nutritional and metabolic disorders, including vitamin deficiencies and inherited metabolic diseases
  3. Neuroendocrinology:
    • Neuroendocrine integration, neuropeptides, and neurotransmitters
    • Stress, circadian rhythms, and their effects on endocrine and metabolic systems
    • Psychiatric and cognitive effects of endocrine disorders
  4. Hormone Replacement and Therapeutics:
    • Innovations in hormone replacement therapies and endocrine interventions
    • Pharmacological advances and novel therapeutic approaches for metabolic and endocrine disorders
    • Biomarkers and diagnostic techniques for improved patient care
  5. Clinical Studies and Trials:
    • Clinical trials of endocrine and metabolic therapies
    • Evidence-based approaches to the treatment of endocrine and metabolic diseases
    • Epidemiological studies on the prevalence, risk factors, and genetic influences of endocrine and metabolic disorders
  6. Translational Research:
    • Studies bridging basic science and clinical applications in endocrinology and metabolism
    • Emerging molecular and genetic mechanisms underlying endocrine diseases and metabolic dysregulation
    • Advances in personalized medicine, biomarkers, and gene therapies for endocrine conditions
  7. Technological and Diagnostic Innovations:
    • Novel imaging, diagnostic, and therapeutic technologies in endocrinology and metabolism
    • Artificial intelligence (AI), machine learning, and digital tools in the management of endocrine disorders
    • Minimally invasive procedures and surgical advances for treating endocrine conditions
  8. Public Health and Policy:
    • Population-level interventions and public health strategies addressing endocrine and metabolic disorders
    • Socioeconomic, environmental, and lifestyle factors affecting endocrine health
    • Health policies and programs aimed at the prevention and management of obesity, diabetes, and other metabolic diseases